BIO

Combination Product Policy Analyst, Center for Devices and Radiological Health (CDRH)

FDA

Andrew Yeatts serves as a Combination Product Policy Advisor at the FDA. He develops cross-cutting guidance and policy related to combination products. Andrew has also worked to implement legislation such as the Combination Product Provisions of 21st Century Cures. Prior to joining FDA, Andrew received his Ph.D. in bioengineering from the University of Maryland and his undergraduate degree in biomedical engineering from Bucknell University. Andrew enjoys traveling with his 6 year old daughter and four year old son and lives in Silver Spring, MD.